Recombinant Human Anti-Alemtuzumab Antibody (Kd = 0.2 nM)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- U.S.A
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- antibody
- Category
- Pharmaceuticals
Creative Biolabs
- Verified Certificate
-
8
Product name | Recombinant Human Anti-Alemtuzumab Antibody (Kd = 0.2 nM) | Certification | - |
---|---|---|---|
Category | Pharmaceuticals | Ingredients | - |
Keyword | antibody | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | U.S.A | Stock | - |
Supply type | - | HS code | - |
Product Information
Recombinant human monoclonal antibody to Alemtuzumab. This product is an anti-idiotypic human IgG1 antibody which is specific for the monoclonal antibody drug Alemtuzumab. It can be used for ELISA, neutralization and other assays.
Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath andCampath-1H, and in the treatment of multiple sclerosis as Lemtrada.
https://www.creativebiolabs.net/Anti-Alemtuzumab-Antibody-71651.htm
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Mr
- Address
- SUITE 203, 17 Ramsey Road, Shirley, NY 11967, USA
- Product Category
- Other Pharmaceutical Chemicals
- Year Established
- 2005
- Company introduction
-
Creative Biolabs is a leading company of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world.Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, nanobodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, nanobody, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.
- Main Product